Cuba's Much-Lauded Medical System Starts New Trial for HIV Vaccine teleSUR
go to original February 27, 2017

According to the Cuban Ministry of Public Health, 31 years after the first case diagnosed in the country with HIV, transmission by blood and its derivatives and mother-to-child transmission were eliminated. (ACN)

Scientists in Cuba are currently undertaking phase one of a clinical trial for a vaccine to help improve the health of people who are HIV positive, Cuban media reported last week.

The vaccine, TERAVAC-VIH, while not intended to give patients a cure for HIV, allows patients to improve their quality of life by reducing the amount of HIV in a patient's blood, known as the viral load. The vaccine is administered nasally, orally and through a spray and injection.

So far, the vaccine has been tested on nine patients who have not shown any adverse effects or toxicity, one of the researchers behind the project Yayri Caridad Prieto Correa told Cuban media outlet ACN.

Prieto Correa and a team of scientists from the Center for Genetic Engineering and Biotechnology in Havana presented their project at the first Congress BioProcess 2017, which takes place on the island’s third biggest city Camaguey.

Prieto Correa said that the long-term project will go through several more testing phases to determine if it should continue. She added that it was important to find more patients for testing. Tests on patients and animals in laboratories have so far suggested that the vaccine has improved immune responses and lowered the viral load in patients.

Read the rest at teleSUR

We invite you to add your charity or supporting organizations' news stories and coming events to PVAngels so we can share them with the world. Do it now!